Lumexa Imaging HoldingsLMRI +14.37%8 EBITDA Margin % is 13.18% as of Mar. 2026, which is 10% above its 10-year median of 12.01. GuruFocus rates LMRI with a GF Score™ of 8/100. The stock has 2 warning signs investors should review. Among 817 Medical Devices & Instruments companies, Lumexa Imaging Holdings ranks better than 55.81% on this metric.
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Lumexa Imaging Holdings EBITDA Margin % Related Terms
Lumexa Imaging Holdings EBITDA Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LMRI vs SSII, CBLL, AVR: EBITDA Margin % Comparison
For the Medical Devices subindustry, Lumexa Imaging Holdings's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Lumexa Imaging Holdings EBITDA Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Lumexa Imaging Holdings's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Lumexa Imaging Holdings's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Lumexa Imaging Holdings (LMRI) has a EBITDA Margin % of 13.18% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Lumexa Imaging Holdings and its competitors. This is 10% above median its historical median of 12.01. Over the past decade, Lumexa Imaging Holdings' EBITDA Margin % has ranged from 10.05 to 13.85. According to the industry distribution chart, Lumexa Imaging Holdings ranks #361 out of 817 companies in the Medical Devices & Instruments industry, placing it in the top 44.2%.
Is Lumexa Imaging Holdings' EBITDA Margin % too high?
Lumexa Imaging Holdings' current EBITDA Margin % of 13.18% is 10% above median its 10-year median of 12.01. Over the past 10 years, this metric has ranged from a low of 10.05 to a high of 13.85. The Medical Devices & Instruments industry median EBITDA Margin % is 7.44. Lumexa Imaging Holdings' value of 13.18% is 77.2% above this industry median. Based on the distribution chart, Lumexa Imaging Holdings ranks #361 out of 817 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Lumexa Imaging Holdings has a GF Score™ of 8/100, reflecting its overall financial health beyond just this single metric.
How does Lumexa Imaging Holdings' EBITDA Margin % compare to SSII and CBLL?
According to the Medical Devices & Instruments industry distribution chart, Lumexa Imaging Holdings ranks #361 out of 817 companies for EBITDA Margin %. This puts Lumexa Imaging Holdings in the upper half of its industry. The industry median EBITDA Margin % is 7.44. Lumexa Imaging Holdings' value of 13.18% is 77.2% above this benchmark. Historically, Lumexa Imaging Holdings' own EBITDA Margin % has ranged from 10.05 to 13.85 over the past decade. While the company's 10-year median is 12.01 vs. the industry median of 7.44, Lumexa Imaging Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Medical Devices & Instruments company?
The median EBITDA Margin % among Medical Devices & Instruments companies is 7.44, based on 817 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Lumexa Imaging Holdings's current EBITDA Margin % of 13.18% is 77.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Lumexa Imaging Holdings and its competitors. For the Medical Devices & Instruments industry, the median EBITDA Margin % is 7.44 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Lumexa Imaging Holdings's current EBITDA Margin % is 13.18%, which is 10% above median its own 10-year median of 12.01. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lumexa Imaging Holdings stock overvalued right now?
Lumexa Imaging Holdings (LMRI) has a current EBITDA Margin % of 13.18%. The current EBITDA Margin % is 13.18%, which is 10% above median its 10-year median of 12.01 and 77.2% above the Medical Devices & Instruments industry median of 7.44. Lumexa Imaging Holdings' overall GF Score™ is 8/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Lumexa Imaging Holdings (LMRI), the current EBITDA Margin % is 13.18% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Lumexa Imaging Holdings Inc is a provider of diagnostic imaging services. The company offers a broad range of imaging modalities, including MRI, CT, PET, X-ray, ultrasound, and mammography. Its products and operations are managed and reported in two operating segments: Outpatient Imaging Centers (Outpatient) and Professional Services (Professional). The professional services segment generates revenue from interpreting imaging studies conducted by other parties, mainly hospital imaging departments. The majority of revenue is generated by the Outpatient segment, which performs imaging studies and provides radiologists' interpretations of those studies.
8GF Score
Get the complete analysis for LMRI
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LMRI has been successfully added to your 